uPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R

Abstract

Our outcomes show that not only overexpressed biomarkers promote tumourigenesis, but rather their interactions further potentiate tumour progression. This study emphasises the potential of combined approaches targeting uPAR and its interactors with regard to an improved therapy of TNBC.